MS

Manik Sopan Kalasare

Active Director Director DIN 07696356
DIN 07696356 First appointment Jan 2017 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Manik Sopan Kalasare

Data last updated:

Manik Sopan Kalasare is a Director at Mayank Ayurveda And Healthcare Therapy Private Limited (since 2017). The company operates in Trading.

DIN 07696356
Primary Designation Director
Industry Trading
First Appointment 02 Jan 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jan 20172017Active

Directorship timeline

Open interactive timeline →
Mayank Ayurveda And Healthcare Therapy Private Limited
Premium access

Shareholding and investment profile for Manik Sopan Kalasare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manik Sopan Kalasare

Manik Sopan Kalasare currently holds 1 directorship: Mayank Ayurveda And Healthcare Therapy Private Limited (Director, since 02 Jan 2017).

Manik Sopan Kalasare was first appointed on 02 Jan 2017 as Director at Mayank Ayurveda And Healthcare Therapy Private Limited.

The current boards of Manik Sopan Kalasare's companies include Dhanesh Murlidhar Vichare (Mayank Ayurveda And Healthcare Therapy Private Limited), Nayna Pramod Vichare (Mayank Ayurveda And Healthcare Therapy Private Limited), Pramod Tukaram Vichre (Mayank Ayurveda And Healthcare Therapy Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available